首页> 外文OA文献 >Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

【2h】

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

机译：苦瓜（苦瓜）提取物通过靶向AMPK信号级联来抑制卵巢癌细胞的致瘤性并克服顺铂耐药性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yung Mingo M H; Ross Fiona A.; Hardie D. Grahame; Leung Thomas H Y; Zhan Jinbiao; Ngan Hextan Y S; Chan David W.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade [J] . Yung Mingo M. H., Ross Fiona A., Hardie D. Grahame, Integrative cancer therapies . 2016,第3期

机译：苦瓜提取物可通过靶向AMPK信号级联来抑制卵巢癌细胞的致瘤性并克服顺铂耐药性。
2. Bitter Melon ( Momordica charantia ) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade [J] . Mingo M. H. Yung, Fiona A. Ross, D. Grahame Hardie, Integrative cancer therapies. . 2016,第3期

机译：苦瓜（苦瓜）提取物通过靶向AMPK信号级联抑制卵巢癌细胞的致瘤性并克服顺铂耐药性
3. Bitter Melon ( Momordica charantia ) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade [J] . Mingo M. H. Yung, Fiona A. Ross, D. Grahame Hardie, Integrative cancer therapies. . 2016,第3期

机译：苦瓜（苦瓜）提取物通过靶向AMPK信号级联抑制卵巢癌细胞的致瘤性并克服顺铂耐药性
4. Culinary Model Innovation on Some Bitter Melon Cultivar (Momordica Charantia L.) Cultivar with High Pectin, Protein, and Diosgenin Characteristics [C] . Ummi Rohajatien, Mazarina Devi, Titi Mutiara K International Conference on Social, Applied Science and Technology in Home Economics . 2020

机译：具有高果胶，蛋白质和二烯素特征的诸如苦瓜品种（MOMORDICA Charantia L.）品种的烹饪模型创新
5. In-Vivo and In-Vitro Drug-Herb Interaction Between Bitter Melon (Momordica Charantia L.) and Glimepiride in Diabetes Mellitus [D] . Abu-Mahfouz, Marah Khaled. 2021

机译：苦瓜（Momordica Charantia L.）和糖尿病中的胶质脂素之间的体内和体外药草相互作用
6. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade [O] . Mingo M. H. Yung, Fiona A. Ross, D. Grahame Hardie, 2016

机译：苦瓜（苦瓜）提取物通过靶向AMPK信号级联来抑制卵巢癌细胞的致瘤性并克服顺铂耐药性
7. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade [O] . Chan, DW, Ngan, HYS, Zhan, J, 2015

机译：苦瓜（momordica charantia）提取物通过靶向ampK信号级联抑制肿瘤发生并克服卵巢癌细胞中的顺铂耐药性

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

著录项

引文网络

相似文献

相关主题

期刊订阅